Myriad Genetics MYGN Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$399.9M-294% | -$365.9M-187% | -$400.5M-245% | -$395.2M-155% | -$101.4M+56.8% | ||
| $51.8M-13.5% | $53.7M-12.3% | $55.9M-9.1% | $58.9M-1.8% | $59.9M+2.9% | ||
| $32.2M-31.9% | $35.2M-29.3% | $43.3M-12.2% | $43.5M-10.3% | $47.3M+4.6% | ||
| $324.8M+486% | $319.4M+464% | $359.7M+2,545% | $360.5M+2,716% | $55.4M+4,517% | ||
| $3.3M— | -$6.2M— | —— | —— | —— | ||
| —— | —— | $5.4M— | $2.5M— | $5.3M— | ||
| $4M— | -$1.4M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$1M-233% | -$2M— | -$1.5M-150% | $0+100% | -$300K+90.3% | ||
| $4.3M— | $3.6M— | $2.1M— | $900K— | —— | ||
| $5.9M-41.0% | $7.7M-18.9% | $9.4M0.0% | $10.7M+8.1% | $10M-6.5% | ||
| $2.4M— | $1.8M— | —— | —— | —— | ||
| $9.9M-16.1% | $11.8M+10.3% | $12.8M+17.2% | $12.2M+14.6% | $11.8M+24.5% | ||
| -$25.6M— | -$27.4M— | -$27.3M— | —— | —— | ||
| —— | —— | —— | —— | $100M-28.6% | ||
| —— | —— | —— | —— | $80M-20.0% | ||
| —— | —— | $400K0.0% | $400K0.0% | $400K+33.3% | ||
| $4.4M-58.1% | $7.3M-45.5% | $7.3M-46.7% | $10M-22.5% | $10.5M-16.7% | ||
| —— | —— | —— | —— | —— | ||
| $600K— | $800K— | $0— | —— | —— | ||
| $28.5M— | $42.9M— | —— | —— | —— | ||
| $324.8M— | $319.4M— | $359.7M— | $360.5M— | —— | ||
| $7.3M— | -$200K— | —— | —— | —— | ||
| -$12.3M— | -$4.4M— | -$3.2M— | —— | —— | ||
| $63.8M+285% | $32.5M+1,400% | -$35.2M-604% | -$34.9M-627% | -$34.4M-632% | ||
| $5.9M-41.0% | $7.7M-18.9% | $9.4M0.0% | $10.7M+8.1% | $10M-6.5% | ||
| $9.9M-16.1% | $11.8M+10.3% | $12.8M+17.2% | $12.2M+14.6% | $11.8M+24.5% | ||
| $15.7M-10.8% | $15.6M-17.9% | $14.5M-42.9% | $15.2M-53.7% | $17.6M-62.1% | ||
| —— | —— | $400K0.0% | $400K0.0% | $400K+33.3% | ||
| —— | $7.5M— | $5.63M— | $3.75M— | $1.88M— | ||
| —— | $0— | $0-100% | $0-100% | $0-100% | ||
| —— | -$200K+50.0% | -$250K+28.6% | -$300K0.0% | -$350K-40.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Myriad Genetics generate?
- Myriad Genetics (MYGN) generated $2.4M in operating cash flow over the trailing twelve months.
- Where does Myriad Genetics's cash flow data come from?
- Every line is extracted from Myriad Genetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
